Biểu đồ giá cổ phiếu ZBIO
ZBIO Giá
Zenas Biopharma Inc
$21.8
7.89%
$1.59
Khi đóng cửa: Jun 24, 16:00:00 GMT-4
$22.22
1.92%
$0.41
Phiên sau giờ: Jun 24, 20:00:00 GMT-4
Quay lại
Zenas Biopharma Inc (ZBIO) Giá
Thống kê chính
Giá đóng cửa trước
$20.2
Giá mở cửa
$20.45
Phạm vi ngày
$20.12 - $22.22
Phạm vi 52 tuần
$8.91 - $44.6
Khối lượng
766.6K
Khối lượng trung bình
697.2K
Tỷ suất cổ tức
--
EPS (TTM)
-8.45
Vốn hóa thị trường
$1.4B
ZBIO là gì?
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company, which engages in the development and commercialization of transformative immunology-based therapies for patients. The company is headquartered in Waltham, Massachusetts and currently employs 167 full-time employees. The company went IPO on 2024-09-13. The firm's lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The firm is developing obexelimab as a potential immunology and inflammation (I&I) franchise for patients in several autoimmune diseases. The first three indications it is pursuing include immunoglobulin G4-related disease (IgG4-RD), relapsing multiple sclerosis (RMS) and systemic lupus erythematosus (SLE). Its other programs include ZB002 (an anti-TNFα monoclonal antibody), ZB004 (a CTLA-4-Ig fusion), and ZB001 and related programs. ZB002 is a recombinant human monoclonal antibody directed at human TNFα.
